BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2665858)

  • 1. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival.
    Barrett AJ; Horowitz MM; Gale RP; Biggs JC; Camitta BM; Dicke KA; Gluckman E; Good RA; Herzig RH; Lee MB
    Blood; 1989 Aug; 74(2):862-71. PubMed ID: 2665858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.
    Doney K; Fisher LD; Appelbaum FR; Buckner CD; Storb R; Singer J; Fefer A; Anasetti C; Beatty P; Bensinger W
    Bone Marrow Transplant; 1991 Jun; 7(6):453-9. PubMed ID: 1873592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J; Ringdén O
    Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.
    Soiffer RJ; Fairclough D; Robertson M; Alyea E; Anderson K; Freedman A; Bartlett-Pandite L; Fisher D; Schlossman RL; Stone R; Murray C; Freeman A; Marcus K; Mauch P; Nadler L; Ritz J
    Blood; 1997 Apr; 89(8):3039-47. PubMed ID: 9108425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.
    Barrett AJ; Horowitz MM; Pollock BH; Zhang MJ; Bortin MM; Buchanan GR; Camitta BM; Ochs J; Graham-Pole J; Rowlings PA
    N Engl J Med; 1994 Nov; 331(19):1253-8. PubMed ID: 7935682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children.
    Woolfrey AE; Anasetti C; Storer B; Doney K; Milner LA; Sievers EL; Carpenter P; Martin P; Petersdorf E; Appelbaum FR; Hansen JA; Sanders JE
    Blood; 2002 Mar; 99(6):2002-8. PubMed ID: 11877272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?
    Ringdén O; Horowitz MM; Sondel P; Gale RP; Biggs JC; Champlin RE; Deeg HJ; Dicke K; Masaoka T; Powles RL
    Blood; 1993 Feb; 81(4):1094-101. PubMed ID: 8427991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Barrett AJ; Horowitz MM; Ash RC; Atkinson K; Gale RP; Goldman JM; Henslee-Downey PJ; Herzig RH; Speck B; Zwaan FE
    Blood; 1992 Jun; 79(11):3067-70. PubMed ID: 1586748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
    Woolfrey AE; Gooley TA; Sievers EL; Milner LA; Andrews RG; Walters M; Hoffmeister P; Hansen JA; Anasetti C; Bryant E; Appelbaum FR; Sanders JE
    Blood; 1998 Nov; 92(10):3546-56. PubMed ID: 9808546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive therapy followed by bone marrow transplantation for patients with acute lymphocytic leukemia in second or subsequent remission: determination of prognostic factors (a report from the University of Minnesota Bone Marrow Transplantation Team).
    Woods WG; Nesbit ME; Ramsay NK; Krivit W; Kim TH; Goldman A; McGlave PB; Kersey JH
    Blood; 1983 Jun; 61(6):1182-9. PubMed ID: 6340756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
    Dopfer R; Henze G; Bender-Götze C; Ebell W; Ehninger G; Friedrich W; Gadner H; Klingebiel T; Peters C; Riehm H
    Blood; 1991 Nov; 78(10):2780-4. PubMed ID: 1824271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia.
    Aversa F; Terenzi A; Carotti A; Felicini R; Jacucci R; Zei T; Latini P; Aristei C; Santucci A; Martelli MP; Cunningham I; Reisner Y; Martelli MF
    J Clin Oncol; 1999 May; 17(5):1545-50. PubMed ID: 10334542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party.
    Barrett AJ; Locatelli F; Treleaven JG; Gratwohl A; Szydło R; Zwaan FE
    Br J Haematol; 1991 Dec; 79(4):567-74. PubMed ID: 1772778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
    Ringdén O; Labopin M; Gorin NC; Schmitz N; Schaefer UW; Prentice HG; Bergmann L; Jouet JP; Mandelli F; Blaise D; Fouillard L; Frassoni F;
    Br J Haematol; 2000 Dec; 111(4):1130-7. PubMed ID: 11167752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.
    Rocha V; Cornish J; Sievers EL; Filipovich A; Locatelli F; Peters C; Remberger M; Michel G; Arcese W; Dallorso S; Tiedemann K; Busca A; Chan KW; Kato S; Ortega J; Vowels M; Zander A; Souillet G; Oakill A; Woolfrey A; Pay AL; Green A; Garnier F; Ionescu I; Wernet P; Sirchia G; Rubinstein P; Chevret S; Gluckman E
    Blood; 2001 May; 97(10):2962-71. PubMed ID: 11342418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.
    Boulad F; Steinherz P; Reyes B; Heller G; Gillio AP; Small TN; Brochstein JA; Kernan NA; O'Reilly RJ
    J Clin Oncol; 1999 Jan; 17(1):197-207. PubMed ID: 10458234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelated donor marrow transplantation in children.
    Balduzzi A; Gooley T; Anasetti C; Sanders JE; Martin PJ; Petersdorf EW; Appelbaum FR; Buckner CD; Matthews D; Storb R; Sullivan KM; Hansen JA
    Blood; 1995 Oct; 86(8):3247-56. PubMed ID: 7579422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.